Early experience with tixagevimab/cilgavimab pre-exposure prophylaxis in patients with immune-mediated inflammatory disease undergoing B cell depleting therapy and those with inborn errors of humoral immunity

Bibliographic Details
Published in:	RMD Open
Main Authors:	Cassandra Calabrese, Elizabeth Kirchner, Alexandra Villa-Forte, Rula A Hajj-Ali, Brandon P Moss, James P Fernandez
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2022-11-01
Online Access:	https://rmdopen.bmj.com/content/8/2/e002557.full

Internet